At a cut-off-level of 5% positive cells, PD-L1 expression in tumor cells was most commonly seen in oncocytomas (41.7%), clearly less frequent in chromophobe (18.8%) and papillary RCC (18.2%), and even less frequent in clear cell RCC (6.3%, Supplementary Table 1). The gene discussed is CD274; the disease is oncocytic adenoma.